Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition

Food and Function

Volumn 6, Issue 12, 2015, Pages 3746-3759

  Fan, Yanhua ^a,b   Lu, Hongyuan ^a,b   Ma, Hongda ^b   Feng, Fan ^b   Hu, Xiaolong ^a,b   Zhang, Qiao ^a,b   Wang, Jian ^a   Xu, Yongnan ^a   Zhao, Qingchun ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; CELL PROLIFERATION; DISEASES; LIPIDS; PLANT EXTRACTS;

ACTIVE INGREDIENTS; ANTI-CANCER THERAPIES; APOPTOTIC PATHWAYS; AUTOPHOSPHORYLATION; BIOACTIVE COMPOUNDS; CELLULAR MECHANISMS; INHIBITORY ACTIVITY; TRADITIONAL CHINESE MEDICINE;

ENZYMES;

AURORA A KINASE; AURORA B KINASE; FLAVONE DERIVATIVE; GALACTOSIDE; GALLIC ACID; HISPIDULIN; PLANT EXTRACT; PROTEIN KINASE INHIBITOR; QUERCETIN; QUERCETIN-3-O-(6''-GALLOYL) BETA-D-GALACTOPYRANOSIDE;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHEMISTRY; CHINA; DRUG EFFECTS; ERIOCAULACEAE; HEPG2 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

APOPTOSIS; AURORA KINASE A; AURORA KINASE B; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHINA; ERIOCAULACEAE; FLAVONES; GALACTOSIDES; GALLIC ACID; HEP G2 CELLS; HUMANS; PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN KINASE INHIBITORS; QUERCETIN;

EID: 84948734711     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c5fo00371g     Document Type: Article

References (72)

1. A. Forner J. M. Llovet J. Bruix Hepatocellular carcinoma Lancet 2012 379 9822 1245 1255
2. S. F. Altekruse K. A. McGlynn M. E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J. Clin. Oncol. 2009 27 9 1485 1491
3. H. C. Spangenberg R. Thimme H. E. Blum Targeted therapy for hepatocellular carcinoma Nat. Rev. Gastroenterol. Hepatol. 2009 6 423 432
4. J. D. Yang L. R. Roberts Hepatocellular carcinoma: a global view Nat. Rev. Gastroenterol. Hepatol. 2010 7 448 458
5. J. Fu M. Bian Q. Jiang C. Zhang Roles of aurora kinases in mitosis and tumorigenesis Mol. Cancer Res. 2007 5 1 1 10
6. D. Benten G. Keller A. Quaas J. Schrader A. Gontarewicz S. Balabanov T. H. Brummendorf Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model Neoplasia 2009 11 9 934 944
7. R. Gassmann A. Carvalho A. J. Henzing S. Ruchaud D. F. Hudson R. Honda E. A. Nigg D. L. Gerloff W. C. Earnshaw Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle J. Cell Biol. 2004 166 179 191
8. H. Katayama S. Sen Aurora kinase inhibitors as anticancer molecules Biochim. Biophys. Acta 2010 1799 10 829 839
9. K. T. Yang Y. N. Lin S. K. Li T. K. Tang Studying the roles of Aurora-C kinase during meiosis in mouse oocytes Methods Mol. Biol. 2013 957 189 202
10. H. Katayama T. Ota F. Jisaki Y. Ueda T. Tanaka S. Odashima Mitotic kinase expression and colorectal cancer progression J. Natl. Cancer Inst. 1999 91 1160 1162
11. T. Tong Y. Zhong J. Kong L. Dong Y. Song M. Fu Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma Clin. Cancer Res. 2004 10 7304 7310
12. E. C. Lee A. Frolov R. Li G. Ayala N. M. Greenberg Targeting Aurora kinases for the treatment of prostate cancer Cancer Res. 2006 66 4996 5002
13. D.-F. Lee J. Su Y.-S. Ang X. Carvajal-Vergara S. Mulero-Navarro C. F. Pereira A. Sevilla Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling Cell Stem Cell 2012 11 2 179 194
14. R. Giet D. M. Glover Drosophila Aurora-B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis J. Cell Biol. 2001 152 4 669 682
15. Y. Wei L. Yu J. Bowen M. A. Gorovsky C. D. Allis Phosphorylation of histone H3 is required for proper chromosome condensation and segregation Cell 1999 97 1 99 109
16. V. Gerben M. A. L. Susanne The Aurora kinase family in cell division and cancer Biochim. Biophys. Acta 2008 1786 60 72
17. G. Mountzios E. Terpos M. A. Dimopoulos Aurora kinases as targets for cancer therapy Cancer Treat. Rev. 2008 34 175 182
18. H. Katalin M. Gábor Mitotic Failures in Cancer: Aurora B Kinase and its Potential Role in the Development of Aneuploidy Pathol. Oncol. Res. 2012 18 4 761 769
19. D. G. Alferez R. A. Goodlad R. Odedra P. Sini C. Crafter A. J. Ryan R. W. Wilkinson Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia Int. J. Oncol. 2012 41 4 1475 1485
20. N. D. Adams J. L. Adams J. L. Burgess A. M. Chaudhari R. A. Copeland C. A. Donatelli M. A. Hardwicke Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase J. Med. Chem. 2010 53 10 3973 4001
21. J. E. Jung T. K. Kim J. S. Lee S. Y. Oh S. Kwak X. Jin J. Y. Sohn M. K. Song Y. W. Sohn S. Y. Lee X. Pian J. B. Lee Y. G. Chung Y. K. Choi S. You H. Kim Survivin inhibits anti-growth effect of p53 activated by aurora B Biochem. Biophys. Res. Commun. 2005 336 4 1164 1171
22. H. Li W. K. K. Wu Z. Zheng C. T. Che Z. J. Li D. D. Xu M. Wang 3,3′,4,5,5′-pentahydroxy-trans-stilbene, a resveratrol derivative, induces apoptosis in colorectal carcinoma cells via oxidative stress Eur. J. Pharmacol. 2010 637 1 55 61
23. X.F Huang S. K. Luo J. Xu J. Li D.R Xu L.H Wang M. Yan X.R Wang X.B Wan F.M Zheng Y.X Zeng Q. Liu Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia Blood 2008 111 5 2854 2865
24. C.-Y. Chien H.-T. Tsai L.-J. Su H.-C. Chuang L.-Y. Shiu C.-C. Huang F.-M. Fang C.-C. Yu H.-T. Su C.-H. Chen Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior Oncotarget 2014 5 8 2243
25. R. Giet C. Petretti C. Prigent Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol. 2005 15 241 250
26. A. Sistayanarain K. Tsuneyama H. Zheng H. Takahashi K. Nomoto C. Cheng Y. Takano Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma Anticancer Res. 2006 26 5A 3585 3593
27. Z. Z. Lin H. C. Hsu C. H. Hsu P. Y. Yeh C. Y. F. Huang Y. F. Huang A. L. Cheng The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma J. Hepatol. 2009 50 3 518 527
28. E. A. Harrington D. Bebbington J. Moore R. K. Rasmussen A. O. Ajose-Adeogun T. Nakayama J. A. Graham C. Demur T. Hercend A. Diu-Hercend M. Su J. M. C. Golec K. M. Miller VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo Nat. Med. 2004 10 262 267
29. A.-L. Salmela J. Pouwels A. Kukkonen-Macchi S. Waris P. Toivonen K. Jaakkola M. J. Kallio The flavonoid eupatorin inactivates the mitotic checkpoint leading to polyploidy and apoptosis Exp. Cell Res. 2012 318 5 578 592
30. F. Xie Q. Lang M. Zhou H. Zhang Z. Zhang Y. Zhang L. Yu The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells Eur. J. Pharm. Sci. 2012 46 5 388 396
31. J. Li Q. Lang H. Zhang Q. Huang L. Yu S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line Biotechnol. Lett. 2013 35 6 853 860
32. State Administration of Traditional Chinese Medicine, Chinese Materia Medica (Zhonghua Bencao), Shanghai Science & Technology Press, Shanghai, 1999, vol. 8. pp. 313-316
33. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China, Chinese Medical Science and Technology Press, 2010, vol. 1, p. 168
34. M. Wang Z. Zhang L. Cheang Z. Lin S. Lee Eriocaulon buergerianum extract protects PC12 cells and neurons in zebrafish against 6-hydroxydopamine-induced damage Chin. Med. J. 2011 6 16
35. X. Qiao G. Ye C. F. Liu Z. X. Zhang Q. Tu J. Dong Y. Q. Li D. A. Guo M. Ye Chemical analysis of Eriocaulon buergerianum and adulterating species by high-performance liquid chromatography with diode array detection and electrospray ionization tandem mass spectrometry J. Pharm. Biomed. Anal. 2012 57 133 142
36. J. A. Duke and E. S. Ayensu, Medicinal plants of China, Reference Publications, Inc, Algonac, Michigan, USA, 1985. vol. 1. pp. 52-361
37. J. A. Duke and E. S. Ayensu, Medicinal Plants of China, Reference Publications, Inc, Algonac, Michigan, USA, 1985, vol. 2, pp. 363-705
38. J. G. Graham M. L. Quinn D. S. Fabricant N. R. Farnsworth Plants used against cancer-an extension of the work of Jonathan Hartwell J. Ethnopharmacol. 2000 73 347 377
39. Chinese Pharmaceutical Association, Pharmacy Dictionary, Shanghai Science & Technology Press, 2006, p. 340
40. A. Ali N. El-Emary M. El-Moghazi F. Darwish A. Frahm Three isoflavonoids from Iris germanica Phytochemistry 1983 22 9 2061 2063
41. J. Sun X. M. He M. M. Zhao L. Li C. B. Li Y. Dong Antioxidant and Nitrite-Scavenging Capacities of Phenolic Compounds from Sugarcane (Saccharum officinarum L.) Tops Molecules 2014 19 9 13147 13160
42. T. Masuda K. Iritani S. Yonemori Y. Oyama Y. Takeda Isolation and antioxidant activity of galloyl flavonol glycosides from the seashore plant, Pemphis acidula Biosci., Biotechnol., Biochem. 2001 65 6 1302 1309
43. J. Im Lee C. S. Kong M. E. Jung J. W. Hong S. Y. Lim Y. Seo Antioxidant activity of the halophyte Limonium tetragonum and its major active components Biotechnol. Bioprocess Eng. 2011 16 5 992 999
44. J. J. Fang G. Ye W. L. Chen W. M. Zhao Antibacterial phenolic components from Eriocaulon buergerianum Phytochemistry 2008 69 5 1279 1286
45. X. Zhu H. Zhang R. Lo Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their timicrobial activities J. Agric. Food Chem. 2004 52 24 7272 7278
46. Y. H. Liao P. J. Houghton J. R. S. Hoult Novel and known constituents from Buddleja species and their activity against leukocyte eicosanoid generation J. Nat. Prod. 1999 62 9 1241 1245
47. J. Zhang Z. Q. Yin P. Cao Y. B. Li J. A. Duan A new flavonol derivative from Fagopyrum dibotrys Chem. Nat. Compd. 2008 44 6 701 703
48. L.L Wang M.X Jiang S.X Xu Q.S Sun G.Y Zeng Y. J. Zhou Two acylated flavonoid glycosides from the leaves of Quercus dentata Nat. Prod. Commun. 2010 5 10 1597 1599
49. D. Gutzeit V. Wray P. Winterhalter G. Jerz Preparative isolation and purification of flavonoids and protocatechuic acid from sea buckthorn juice concentrate (Hippophae rhamnoides L. ssp. rhamnoides) by high-speed counter-current chromatography Chromatographia 2007 65 1-2 1 7
50. E. F. Batista D. M. Costa G. M. Guilhon A. H. Muller L. S. Santos M. S. P. Arruda R. S. Secco Chemical constituents and allelopathic and antioxidant activities of Alchorneopsis floribunda Müll. Arg.(Euphorbiaceae) Nat. Prod. Res. 2013 27 1 1 8
51. F. Sessa F. Villa Structure of Aurora B-INCENP in complex with barasertib reveals a potential transinhibitory mechanism Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2014 70 294 298
52. J.-C. Carry F. Clerc H. Minoux L. Schio J. Mauger A. Nair E. Parmantier R. Le Moigne C. Delorme J.-P. Nicolas SAR156497, an Exquisitely Selective Inhibitor of Aurora Kinases J. Med. Chem. 2014 58 1 362 375
53. J. J. Meng Y. H. Fan M. Z. Su C. Q. Chen T. S. Ren WLIP derived from Lasiosphaera fenzlii Reich exhibits anticancer activity and induces cell cycle arrest through PPAR-γ associated pathways Int. Immunopharmacol. 2014 19 37 44
54. A. Yan L. Wang S. Xu J. Xu Aurora-A kinase inhibitor scaffolds and binding modes Drug Discovery Today 2011 16 5 260 269
55. T. Hata T. Furukawa M. Sunamura S. Egawa F. Motoi N. Ohmura T. Marumoto H. Saya A. Horii RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells Cancer Res. 2005 65 7 2899 2905
56. S. Hauf R. W. Cole S. LaTerra C. Zimmer G. Schnapp R. Walter A. Heckel M. J. Vaneel C. L. Rieder J.-M. Peters The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint J. Cell Biol. 2003 161 2 281 294
57. P. Romé E. Montembault N. Franck A. Pascal D. M. Glover R. Giet Aurora A contributes to p150glued phosphorylation and function during mitosis J. Cell Biol. 2010 189 4 651 659
58. Y. Yasui T. Urano A. Kawajiri K. Nagata M. Tatsuka H. Saya K. Furukawa T. Takahashi I. Izawa M. Inagaki Autophosphorylation of a newly identified site of Aurora-B is indispensable for cytokinesis J. Biol. Chem. 2004 279 12997 13003
59. J.-Y. Hsu Z.-W. Sun X. Li M. Reuben K. Tatchell D. K. Bishop D. F. Hunt Mitotic phosphorylation of histone h3 is governed by ipl1/aurora kinase and glc7/pp1 phosphatase in budding yeast and nematodes Cell 2000 102 3 279 291
60. T. Ikezoe J. Yang C. Nishioka A. Yokoyama p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells Int. J. Hematol. 2010 91 69 77
61. F. Gizatullin Y. Yao V. Kung M. W. Harding M. Loda G. I. Shapiro The aurora kinase inhibitor vx-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function Cancer Res. 2006 66 15 7668 7677
62. K. Kojima M. Konopleva T. Tsao H. Nakakuma M. Andreeff Concomitant inhibition of mdm2-p53 interaction and aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia Blood 2008 112 7 2886 2895
63. M. Li A. Jung U. Ganswindt P. Marini A. Friedl P. T. Daniel C. Belka Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways Biochem. Pharmacol. 2010 79 2 122 129
64. K. Hiroshi W. R. Brinkley S. Sen The Aurora kinases: Role in cell transformation and tumorigenesis Cancer Metastasis Rev. 2003 22 4 451 464
65. J. Curry H. Angove L. Fazal J. Lyons M. Reule N. Thompson N. Wallis Aurora B kinase inhibition in mitosis Cell Cycle 2009 8 12 1921 1929
66. L. He Y. Wu L. Lin J. Wang Y. Wu Y. Chen Z. Yi M. Liu X. Pang Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3 K/Akt/mTOR signaling pathway Cancer Sci. 2011 102 1 219 225
67. J. Du G. J. Hannon Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion Proc. Natl. Acad. Sci. U. S. A. 2004 101 8975 8980
68. M. J. Kallio M. L. McCleland P. T. Stukenberg G. J. Gorbsky Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis Curr. Biol. 2002 12 11 900 905
69. S. Geuns-Meyer V. J. Cee H. L. Deak B. Du B. L. Hodous H. N. Nguyen P. R. Olivieri K. Romero L. B. Schenkel V. F. Patel Discovery of AMG 900, a highly selective, orally bioavailable inhibitor of aurora kinases with efficacy in preclinical antitumor models and activity against multidrug-resistant cells Cancer Res. 2010 70 8 Supplement 5776 5776
70. H. J. Kim J. H. Cho H. Quan J. R. Kim Down-regulation of Aurora B kinase induces cellular senescence in human fibroblasts and endothelial cells through a p53-dependent pathway FEBS Lett. 2011 585 22 3569 3576
71. K. H. Vousden X. Lu Live or let die: the cell's response to p53 Nat. Rev. Cancer 2002 2 8 594 604
72. U. Moll N. Marchenko X. Zhang p53 and Nur77/TR3-transcription factors that directly target mitochondria for cell death induction Oncogene 2006 25 34 4725 4743